» Articles » PMID: 8177321

The Stress-activated Protein Kinase Subfamily of C-Jun Kinases

Overview
Journal Nature
Specialty Science
Date 1994 May 12
PMID 8177321
Citations 607
Authors
Affiliations
Soon will be listed here.
Abstract

The mitogen-activated protein (MAP) kinases Erk-1 and Erk-2 are proline-directed kinases that are themselves activated through concomitant phosphorylation of tyrosine and threonine residues. The kinase p54 (M(r) 54,000), which was first isolated from cycloheximide-treated rats, is proline-directed like Erks-1/2, and requires both Tyr and Ser/Thr phosphorylation for activity. p54 is, however, distinct from Erks-1/2 in its substrate specificity, being unable to phosphorylate pp90rsk but more active in phosphorylating the c-Jun transactivation domain. Molecular cloning of p54 reveals a unique subfamily of extracellularly regulated kinases. Although they are 40-45% identical in sequence to Erks-1/2, unlike Erks-1/2 the p54s are only poorly activated in most cells by mitogens or phorbol esters. However, p54s are the principal c-Jun N-terminal kinases activated by cellular stress and tumour necrosis factor (TNF)-alpha, hence they are designated stress-activated protein kinases, or SAPKs. SAPKs are also activated by sphingomyelinase, which elicits a subset of cellular responses to TNF-alpha (ref. 9). SAPKs therefore define a new TNF-alpha and stress-activated signalling pathway, possibly initiated by sphingomyelin-based second messengers, which regulates the activity of c-Jun.

Citing Articles

Dopamine increases protein synthesis in hippocampal neurons enabling dopamine-dependent LTP.

Fuchsberger T, Stockwell I, Woods M, Brzosko Z, Greger I, Paulsen O Elife. 2025; 13.

PMID: 40063079 PMC: 11893101. DOI: 10.7554/eLife.100822.


Targeting skeletal interoception: a novel mechanistic insight into intervertebral disc degeneration and pain management.

Zhu H, Ren J, Wang X, Qin W, Xie Y J Orthop Surg Res. 2025; 20(1):159.

PMID: 39940003 PMC: 11823264. DOI: 10.1186/s13018-025-05577-7.


Impact of c-JUN deficiency on thalamus development in mice and human neural models.

Shi J, Chen Q, Lai J, Zhu J, Zhang R, Mazid M Cell Biosci. 2024; 14(1):149.

PMID: 39707500 PMC: 11662577. DOI: 10.1186/s13578-024-01303-8.


SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1).

Zhong B, Zhang Y, Zheng H, Chen Q, Lu H, Chen X Acta Pharmacol Sin. 2024; .

PMID: 39587283 DOI: 10.1038/s41401-024-01418-1.


The JNK signaling pathway in intervertebral disc degeneration.

Liu G, Gao L, Wang Y, Xie X, Gao X, Wu X Front Cell Dev Biol. 2024; 12:1423665.

PMID: 39364138 PMC: 11447294. DOI: 10.3389/fcell.2024.1423665.